Stocks
Hologic Financial Statements (HOLX) |
||||||||||
| Hologicsmart-lab.ru | % | 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 16.11.2021 | 24.09.2022 | 15.11.2022 | 30.09.2023 | 21.11.2023 | 02.02.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 5 632 | 4 863 | 4 863 | 4 030 | 4 030 | 3 888 | |||
| Operating Income, bln rub | 2 480 | 1 640 | 1 640 | 668.4 | 668.4 | 464.6 | ||||
| EBITDA, bln rub | ? | 2 886 | 1 773 | 2 105 | 1 204 | 1 204 | 976.6 | |||
| Net profit, bln rub | ? | 1 872 | 1 302 | 1 302 | 456.0 | 456.0 | 387.2 | |||
| OCF, bln rub | ? | 2 330 | 2 126 | 2 126 | 1 051 | 1 051 | 1 070 | |||
| CAPEX, bln rub | ? | 162.7 | 70.6 | 127.2 | 150.2 | 150.2 | 179.5 | |||
| FCF, bln rub | ? | 2 168 | 2 055 | 1 999 | 901.0 | 901.0 | 890.7 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 1 313 | 1 357 | 1 367 | 1 310 | 1 310 | 1 284 | ||||
| Cost of production, bln rub | 1 837 | 1 865 | 1 865 | 1 959 | 1 959 | 1 953 | ||||
| R&D, bln rub | 276.3 | 283.4 | 283.4 | 294.3 | 294.3 | 285.2 | ||||
| Interest expenses, bln rub | 93.6 | 95.1 | 95.1 | 111.1 | 111.1 | 109.9 | ||||
| Assets, bln rub | 8 920 | 9 071 | 9 071 | 9 139 | 9 139 | 8 470 | ||||
| Net Assets, bln rub | ? | 4 219 | 4 876 | 4 876 | 5 017 | 5 017 | 4 654 | |||
| Debt, bln rub | 3 025 | 2 823 | 2 823 | 2 818 | 2 818 | 2 578 | ||||
| Cash, bln rub | 1 170 | 2 340 | 2 340 | 2 723 | 2 723 | 1 932 | ||||
| Net debt, bln rub | 1 855 | 483.9 | 483.9 | 95.7 | 95.7 | 645.9 | ||||
| Ordinary share price, rub | 76.5 | 63.0 | 63.0 | 69.4 | 69.4 | 66.6 | ||||
| Number of ordinary shares, mln | 257.0 | 251.5 | 251.5 | 246.8 | 246.8 | 238.6 | ||||
| Market cap, bln rub | 19 659 | 15 841 | 15 841 | 17 126 | 17 126 | 15 883 | ||||
| EV, bln rub | ? | 21 514 | 16 325 | 16 325 | 17 222 | 17 222 | 16 529 | |||
| Book value, bln rub | -722 | 4 876 | 359 | 5 017 | 847 | 515 | ||||
| EPS, rub | ? | 7.28 | 5.18 | 5.18 | 1.85 | 1.85 | 1.62 | |||
| FCF/share, rub | 8.43 | 8.17 | 7.95 | 3.65 | 3.65 | 3.73 | ||||
| BV/share, rub | -2.81 | 19.4 | 1.43 | 20.3 | 3.43 | 2.16 | ||||
| EBITDA margin, % | ? | 51.2% | 36.5% | 43.3% | 29.9% | 29.9% | 25.1% | |||
| Net margin, % | ? | 33.2% | 26.8% | 26.8% | 11.3% | 11.3% | 9.96% | |||
| FCF yield, % | ? | 11.0% | 13.0% | 12.6% | 5.26% | 5.26% | 5.61% | |||
| ROE, % | ? | 44.4% | 26.7% | 26.7% | 9.09% | 9.09% | 8.32% | |||
| ROA, % | ? | 21.0% | 14.4% | 14.4% | 4.99% | 4.99% | 4.57% | |||
| P/E | ? | 10.5 | 12.2 | 12.2 | 37.6 | 37.6 | 41.0 | |||
| P/FCF | 9.07 | 7.71 | 7.93 | 19.0 | 19.0 | 17.8 | ||||
| P/S | ? | 3.49 | 3.26 | 3.26 | 4.25 | 4.25 | 4.09 | |||
| P/BV | ? | -27.2 | 3.25 | 44.1 | 3.41 | 20.2 | 30.8 | |||
| EV/EBITDA | ? | 7.46 | 9.21 | 7.76 | 14.3 | 14.3 | 16.9 | |||
| Debt/EBITDA | 0.64 | 0.27 | 0.23 | 0.08 | 0.08 | 0.66 | ||||
| R&D/CAPEX, % | 169.8% | 401.4% | 222.8% | 195.9% | 195.9% | 158.9% | ||||
| CAPEX/Revenue, % | 2.89% | 1.45% | 2.62% | 3.73% | 3.73% | 4.62% | ||||
| Hologic shareholders | ||||||||||
